Pharmaceutical Executive
To convey how quickly Alcon's Vigamox resolves pink eye, Corbett Worldwide Healthcare Communications turned to a universally understood icon-the pink eraser-and leveraged it to make the brand stand out in the competitive market.
PINK ERASER
Corbett
BRAND Vigamox CLIENT Alcon FROM LEFT: Eric Loeb, group creative director; Jaime Goldman, senior account director; Peg Gill, copywriter; Cassie Zablotney, account supervisor; Terry Barich, art director; Christina HIllestad, senior project director; Emily Deming, account executive
To convey how quickly Alcon's Vigamox resolves pink eye, Corbett Worldwide Healthcare Communications turned to a universally understood icon—the pink eraser—and leveraged it to make the brand stand out in the competitive market.
The resulting creative used the school-related item to convey how Vigamox could "erase" the disease, and used the word "pink" and the color to link Vigamox to the condition. But what really makes the ad stand out is the childlike illustration style, which puts Vigamox in the world of the pink-eye patients whom doctors see most often.
This deceptively simple concept led to many highly engaging tactics, all using the iconic pink eraser. The two-page medical journal ad took first place in its category at the 2008 Doctor's Choice Awards and was voted most creative at Corbett's 2007 Gallery Awards, an in-house celebration of the agency's best work.
Robin Shapiro, executive vice president, chief creative officer, credits the Corbett team's success with this campaign to the company's unusual philosophy. "Our strategy is to encourage a healthy collision of consumer and pharma talent. We believe that the integration of consumer brand-building expertise with pharma experience enables us to create powerful branding campaigns built around strong scientific insight."
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.